Literature DB >> 19006241

Mutations and polymorphisms in the human argininosuccinate synthetase (ASS1) gene.

Katharina Engel1, Wolfgang Höhne, Johannes Häberle.   

Abstract

Citrullinemia type I is an autosomal recessive disorder that is caused by a deficiency of the urea cycle enzyme argininosuccinate synthetase (ASS1). Deficiency of ASS1 shows various clinical manifestations encompassing severely affected patients with fatal neonatal hyperammonemia as well as asymptomatic individuals with only a biochemical phenotype. This is a comprehensive report of all 87 mutations found to date in the ASS1 gene on chromosome 9q34.1. A large proportion of the mutations (n=27) are described here for the first time. Mutations are distributed throughout exons 3 to 15, most of them being identified in exons 5, 12, 13, and 14. The mutation G390R in exon 15 is the single most common mutation in patients with the classical phenotype. Certain mutations clearly link to specific clinical courses but the clinical phenotype cannot be anticipated in all patients. This update presents a survey of the correlation between mutations in the ASS1 gene and the respective clinical courses as described so far. It also sheds light on the geographic incidence of the mutations. Enzymatic studies have been done in bacterial and human cell systems. However, the prognostic value of genetic aberrations with respect to their effect on protein function and clinical manifestation remains uncertain. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19006241     DOI: 10.1002/humu.20847

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  35 in total

1.  Expanded newborn screening: reducing harm, assessing benefit.

Authors:  Bridget Wilcken
Journal:  J Inherit Metab Dis       Date:  2010-05-04       Impact factor: 4.982

2.  A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity.

Authors:  S-H Chen; W Yang; Y Fan; G Stocco; K R Crews; J J Yang; S W Paugh; C-H Pui; W E Evans; M V Relling
Journal:  Leukemia       Date:  2010-11-12       Impact factor: 11.528

3.  Two hypomorphic alleles of mouse Ass1 as a new animal model of citrullinemia type I and other hyperammonemic syndromes.

Authors:  Carlos J Perez; Jean Jaubert; Jean-Louis Guénet; Kirstin F Barnhart; Catherine M Ross-Inta; Vicente C Quintanilla; Isabelle Aubin; Jimi L Brandon; Nancy W Otto; John DiGiovanni; Irma Gimenez-Conti; Cecilia Giulivi; Donna F Kusewitt; Claudio J Conti; Fernando Benavides
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

4.  Favorable long-term outcome following severe neonatal hyperammonemic coma in a patient with argininosuccinate synthetase deficiency.

Authors:  Isabelle De Bie; Emmanuelle Lemyre; Marie Lambert
Journal:  JIMD Rep       Date:  2011-06-22

5.  Molecular epidemiology of citrullinemia type I in a risk region of Argentina: a first step to preconception heterozygote detection.

Authors:  Laura E Laróvere; Silene M Silvera Ruiz; Celia J Angaroni; Raquel Dodelson de Kremer
Journal:  JIMD Rep       Date:  2012-02-26

6.  Argininosuccinate synthetase regulates hepatic AMPK linking protein catabolism and ureagenesis to hepatic lipid metabolism.

Authors:  Anila K Madiraju; Tiago Alves; Xiaojian Zhao; Gary W Cline; Dongyan Zhang; Sanjay Bhanot; Varman T Samuel; Richard G Kibbey; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

7.  Argininosuccinate synthase conditions the response to acute and chronic ethanol-induced liver injury in mice.

Authors:  Tung Ming Leung; Yongke Lu; Wei Yan; Jose A Morón-Concepción; Stephen C Ward; Xiaodong Ge; Laura Conde de la Rosa; Natalia Nieto
Journal:  Hepatology       Date:  2012-05       Impact factor: 17.425

8.  Regions of homozygosity identified by oligonucleotide SNP arrays: evaluating the incidence and clinical utility.

Authors:  Jia-Chi Wang; Leslie Ross; Loretta W Mahon; Renius Owen; Morteza Hemmat; Boris T Wang; Mohammed El Naggar; Kimberly A Kopita; Linda M Randolph; John M Chase; Maria J Matas Aguilera; Juan López Siles; Joseph A Church; Natalie Hauser; Joseph J Shen; Marilyn C Jones; Klaas J Wierenga; Zhijie Jiang; Mary Haddadin; Fatih Z Boyar; Arturo Anguiano; Charles M Strom; Trilochan Sahoo
Journal:  Eur J Hum Genet       Date:  2014-08-13       Impact factor: 4.246

9.  Clinical outcomes of neonatal onset proximal versus distal urea cycle disorders do not differ.

Authors:  Nicholas Ah Mew; Lauren Krivitzky; Robert McCarter; Mark Batshaw; Mendel Tuchman
Journal:  J Pediatr       Date:  2012-08-15       Impact factor: 4.406

10.  Argininosuccinate synthetase 1 depletion produces a metabolic state conducive to herpes simplex virus 1 infection.

Authors:  Sarah L Grady; John G Purdy; Joshua D Rabinowitz; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.